1-18 of 18
Authors: James M. Boyett
Sort by
Journal Article
Phase II trial of response-based radiation therapy for patients with localized germinoma: a Children’s Oncology Group study
Ute Bartels and others
Neuro-Oncology, Volume 24, Issue 6, June 2022, Pages 974–983, https://doi.org/10.1093/neuonc/noab270
Published: 29 November 2021
Journal Article
LGG-08. A PHASE II PROSPECTIVE STUDY OF SELUMETINIB IN CHILDREN WITH RECURRENT OR REFRACTORY LOW-GRADE GLIOMA (LGG): A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY
Jason Fangusaro and others
Neuro-Oncology, Volume 19, Issue suppl_4, June 2017, Pages iv34–iv35, https://doi.org/10.1093/neuonc/nox083.141
Published: 31 May 2017
Journal Article
A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study
Anuradha Banerjee and others
Neuro-Oncology, Volume 19, Issue 8, August 2017, Pages 1135–1144, https://doi.org/10.1093/neuonc/now282
Published: 28 February 2017
Journal Article
Phase I trial of p28 (NSC745104), a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in pediatric patients with recurrent or progressive central nervous system tumors: A Pediatric Brain Tumor Consortium Study
Rishi R. Lulla and others
Neuro-Oncology, Volume 18, Issue 9, September 2016, Pages 1319–1325, https://doi.org/10.1093/neuonc/now047
Published: 28 March 2016
Journal Article
Apparent diffusion coefficient histogram metrics correlate with survival in diffuse intrinsic pontine glioma: a report from the Pediatric Brain Tumor Consortium
Tina Young Poussaint and others
Neuro-Oncology, Volume 18, Issue 5, May 2016, Pages 725–734, https://doi.org/10.1093/neuonc/nov256
Published: 20 October 2015
Journal Article
MB-32FEASIBILITY OF VORINOSTAT COMBINED WITH ISOTRETINOIN AND CHEMOTHERAPY FOR YOUNG CHILDREN WITH NEWLY DIAGNOSED EMBRYONAL BRAIN TUMORS: A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY
Get access
Sarah Leary and others
Neuro-Oncology, Volume 17, Issue suppl_3, June 2015, Page iii27, https://doi.org/10.1093/neuonc/nov061.108
Published: 21 April 2015
Journal Article
A phase 1 and pharmacokinetic study of enzastaurin in pediatric patients with refractory primary central nervous system tumors: a pediatric brain tumor consortium study
Get access
Lindsay B. Kilburn and others
Neuro-Oncology, Volume 17, Issue 2, February 2015, Pages 303–311, https://doi.org/10.1093/neuonc/nou114
Published: 27 November 2014
Journal Article
Brain Malignancy Steering Committee clinical trials planning workshop: Report from the Targeted Therapies Working Group
Get access
Brian M. Alexander and others
Neuro-Oncology, Volume 17, Issue 2, February 2015, Pages 180–188, https://doi.org/10.1093/neuonc/nou154
Published: 26 August 2014
Journal Article
Benefit from prolonged dose-intensive chemotherapy for infants with malignant brain tumors is restricted to patients with ependymoma: a report of the Pediatric Oncology Group randomized controlled trial 9233/34
Get access
Douglas R. Strother and others
Neuro-Oncology, Volume 16, Issue 3, March 2014, Pages 457–465, https://doi.org/10.1093/neuonc/not163
Published: 12 December 2013
Journal Article
Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas—a Pediatric Brain Tumor Consortium study
Get access
Sridharan Gururangan and others
Neuro-Oncology, Volume 16, Issue 2, February 2014, Pages 310–317, https://doi.org/10.1093/neuonc/not154
Published: 04 December 2013
Journal Article
Phase I trial of capecitabine rapidly disintegrating tablets and concomitant radiation therapy in children with newly diagnosed brainstem gliomas and high-grade gliomas
Get access
Lindsay B. Kilburn and others
Neuro-Oncology, Volume 15, Issue 6, June 2013, Pages 759–766, https://doi.org/10.1093/neuonc/nos315
Published: 16 April 2013
Journal Article
Lack of efficacy of bevacizumab + irinotecan in cases of pediatric recurrent ependymoma—a Pediatric Brain Tumor Consortium study
Get access
Sridharan Gururangan and others
Neuro-Oncology, Volume 14, Issue 11, November 2012, Pages 1404–1412, https://doi.org/10.1093/neuonc/nos213
Published: 26 September 2012
Journal Article
A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: A report from the Pediatric Brain Tumor Consortium
Get access
Ian F. Pollack and others
Neuro-Oncology, Volume 13, Issue 3, March 2011, Pages 290–297, https://doi.org/10.1093/neuonc/noq199
Published: 01 March 2011
Journal Article
Phase II trial of tipifarnib and radiation in children with newly diagnosed diffuse intrinsic pontine gliomas
Get access
Daphne A. Haas-Kogan and others
Neuro-Oncology, Volume 13, Issue 3, March 2011, Pages 298–306, https://doi.org/10.1093/neuonc/noq202
Published: 01 March 2011
Journal Article
MRI as a central component of clinical trials analysis in brainstem glioma: a report from the Pediatric Brain Tumor Consortium (PBTC)
Get access
Tina Young Poussaint and others
Neuro-Oncology, Volume 13, Issue 4, April 2011, Pages 417–427, https://doi.org/10.1093/neuonc/noq200
Published: 04 February 2011
Journal Article
Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma
Get access
Daphne A. Haas-Kogan and others
Neuro-Oncology, Volume 10, Issue 3, June 2008, Pages 341–347, https://doi.org/10.1215/15228517-2008-004
Published: 01 June 2008
Journal Article
Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: A Pediatric Brain Tumor Consortium report
Get access
Ian F. Pollack and others
Neuro-Oncology, Volume 9, Issue 2, April 2007, Pages 145–160, https://doi.org/10.1215/15228517-2006-031
Published: 01 April 2007
Journal Article
The influence of central review on outcome associations in childhood
malignant gliomas: Results from the CCG-945 experience
Get access
Ian F. Pollack and others
Neuro-Oncology, Volume 5, Issue 3, July 2003, Pages 197–207, https://doi.org/10.1215/S1152851703000097
Published: 01 July 2003
Advertisement
Advertisement